HSPA1A and Miyoshi myopathy: Cationic Hsp70 inhibitors such as compound 3b (Figure 4, JG-98) were identified as mortalin inhibitors with pronounced activity against proteasome inhibitor-resistant MM cells associated with 55S mitoribosome degradation [90].